MichaelAaron Flicker examines the growing impact of GLP-1 medications on consumer behavior, noting that roughly one in five American households has someone using a GLP-1 drug. He explains how that trend is reshaping spending habits and discusses the implications for restaurants as well as food and beverage stocks. As MichaelAaron explains, the shift in weight loss habits is creating swift strategy adjustments for companies across the industry.